The REASON (Real world Evidence to evaluAte the clinical utility of copper SpeciatiON assay to measure free copper in subjects with Wilson's disease) STUDY
Real World Evidence Study in Subjects With Wilson's Disease
Sponsor: Orphalan
Enrolling: Male and Female Patients
IRB Number: AAAU6619
U.S. Govt. ID: NCT05783687
Contact: Transplant Clinical Research Center TCRC: /
Additional Study Information: The purpose of this study is to find out if a new laboratory blood test for patients with Wilson's disease can accurately and reliably measure so-called free copper, also known as non-ceruloplasmin copper (NCC). Participation will last about 12 months. If you have any questions regarding this study, please contact the Transplant Clinical Research Center (TCRC).
Steven Lobritto, MD
Do You Qualify?
Are you at least 18 years old? Yes No
Have you been diagnosed with Wilson's Disease? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Transplant Clinical Research Center TCRC